A 133 (Bupropion Extended Release (SR) 150 mg)

Pill imprint A 133 has been identified as Bupropion hydrochloride extended release (SR) 150 mg.

Bupropion is used in the treatment of sexual dysfunction, ssri induced; major depressive disorder; depression; adhd; anxiety (and more), and belongs to the drug classes miscellaneous antidepressants, smoking cessation agents. Risk cannot be ruled out during pregnancy. Bupropion 150 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for A 133

Bupropion hydrochloride extended release (SR) 150 mg A 133
Bupropion hydrochloride extended release (SR) 150 mg A 133
Bupropion hydrochloride extended release (SR) 150 mg A 133
Bupropion hydrochloride extended release (SR)
Imprint:
A 133
Strength:
150 mg
Color:
Yellow
Size:
11.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Miscellaneous antidepressants
Smoking cessation agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Actavis
National Drug Code (NDC):
67767-0133
Inactive Ingredients:
copovidone
silicon dioxide
hydroxypropyl cellulose
hypromelloses
magnesium stearate
microcrystalline cellulose
polydextrose
polyethylene glycol
titanium dioxide
triacetin
ferric oxide yellow
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
68084-0471 Amerisource Health Services
18837-0246 Innoviant Pharmacy Inc (repackager)
53002-1345 Pharmedix (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)